Renal heparan sulfate proteoglycans modulate fibroblast growth factor 2 signaling in experimental chronic transplant dysfunction

American Journal of Pathology

Volumn 183, Issue 5, 2013, Pages 1571-1584

  Katta, Kirankumar ^a   Boersema, Miriam ^a   Adepu, Saritha ^a   Rienstra, Heleen ^a   Celie, Johanna W A M ^b   Mencke, Rik ^a   Molema, Grietje ^a   Van Goor, Harry ^a   Berden, Jo H M ^c   Navis, Gerjan ^a   Hillebrands, Jan Luuk ^a   Van Den Born, Jacob ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE; PERLECAN; POLYSACCHARIDE; PROTEOGLYCAN; PROTEOHEPARAN SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CHRONIC DISEASE; CONTROLLED STUDY; FEMALE; GLOMERULUS; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MESANGIUM CELL; NEOINTIMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN MOTIF; RAT; RENAL GRAFT DYSFUNCTION; SIGNAL TRANSDUCTION;

ALLOGRAFTS; AMINO ACID MOTIFS; ANIMALS; CELL MEMBRANE; CELL PROLIFERATION; CHRONIC DISEASE; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; MESANGIAL CELLS; PROTEIN BINDING; PROTEOGLYCANS; RATS; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84886694776     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.07.030     Document Type: Article

References (45)

1. E.A. Kouwenhoven, J.N. IJzermans, and R.W. de Bruin Etiology and pathophysiology of chronic transplant dysfunction Transpl Int 13 2000 385 401
2. J.R. Chapman, P.J. O'Connell, and B.J. Nankivell Chronic renal allograft dysfunction J Am Soc Nephrol 16 2005 3015 3026
3. K. Solez, R.B. Colvin, L.C. Racusen, M. Haas, B. Sis, M. Mengel, P.F. Halloran, W. Baldwin, G. Banfi, A.B. Collins, F. Cosio, D.S. David, C. Drachenberg, G. Einecke, A.B. Fogo, I.W. Gibson, D. Glotz, S.S. Iskandar, E. Kraus, E. Lerut, R.B. Mannon, M. Mihatsch, B.J. Nankivell, V. Nickeleit, J.C. Papadimitriou, P. Randhawa, H. Regele, K. Renaudin, I. Roberts, D. Seron, R.N. Smith, and M. Valente Banff 07 classification of renal allograft pathology: updates and future directions Am J Transplant 8 2008 753 760
4. K. Solez, R.B. Colvin, L.C. Racusen, B. Sis, P.F. Halloran, P.E. Birk, P.M. Campbell, M. Cascalho, A.B. Collins, A.J. Demetris, C.B. Drachenberg, I.W. Gibson, P.C. Grimm, M. Haas, E. Lerut, H. Liapis, R.B. Mannon, P.B. Marcus, M. Mengel, M.J. Mihatsch, B.J. Nankivell, V. Nickeleit, J.C. Papadimitriou, J.L. Platt, P. Randhawa, I. Roberts, L. Salinas-Madriga, D.R. Salomon, D. Seron, M. Sheaff, and J.J. Weening Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') Am J Transplant 7 2007 518 526
5. H. Rienstra, K. Katta, J.W. Celie, H. van Goor, G. Navis, J. van den Born, and J.L. Hillebrands Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats PLoS One 5 2010 e9095
6. J.W. Celie, R.M. Reijmers, E.M. Slot, R.H. Beelen, M. Spaargaren, P.M. Ter Wee, S. Florquin, and J. van den Born Tubulointerstitial heparan sulfate proteoglycan changes in human renal diseases correlate with leukocyte influx and proteinuria Am J Physiol Renal Physiol 294 2008 F253 F263
7. J.W. Celie, N.W. Rutjes, E.D. Keuning, R. Soininen, R. Heljasvaara, T. Pihlajaniemi, A.M. Dräger, S. Zweegman, F.L. Kessler, R.H. Beelen, S. Florquin, J. Aten, and J. van den Born Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion Am J Pathol 170 2007 1865 1878
8. A. Zaferani, R.R. Vives, P. van der Pol, J.J. Hakvoort, G.J. Navis, H. van Goor, M.R. Daha, H. Lortat-Jacob, M.A. Seelen, and J. van den Born Identification of tubular heparan sulfate as a docking platform for the alternative complement component properdin in proteinuric renal disease J Biol Chem 286 2011 5359 5367
9. J.M. Whitelock, J. Melrose, and R.V. Iozzo Diverse cell signaling events modulated by perlecan Biochemistry 47 2008 11174 11183
10. R.V. Iozzo, and R.D. Sanderson Proteoglycans in cancer biology, tumour environment and angiogenesis J Cell Mol Med 15 2011 1013 1031
11. H. Lortat-Jacob The molecular basis and functional implications of chemokine interactions with heparan sulphate Curr Opin Struct Biol 19 2009 543 548
12. S. Guimond, M. Maccarana, B.B. Olwin, U. Lindahl, and A.C. Rapraeger Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4 J Biol Chem 268 1993 23906 23914
13. J.T. Gallagher, and J.E. Turnbull Heparan sulphate in the binding and activation of basic fibroblast growth factor Glycobiology 2 1992 523 528
14. M. Schwabiuk, L. Coudiere, and D.C. Merz SDN-1/syndecan regulates growth factor signaling in distal tip cell migrations in C. elegans Dev Biol 334 2009 235 242
15. G.H. Olivares, H. Carrasco, F. Aroca, L. Carvallo, F. Segovia, and J. Larraín Syndecan-1 regulates BMP signaling and dorso-ventral patterning of the ectoderm during early Xenopus development Dev Biol 329 2009 338 349
16. I. Menashe, D. Maeder, M. Garcia-Closas, J.D. Figueroa, S. Bhattacharjee, M. Rotunno, P. Kraft, D.J. Hunter, S.J. Chanock, P.S. Rosenberg, and N. Chatterjee Pathway analysis of breast cancer genome-wide association study highlights three pathways and one canonical signaling cascade Cancer Res 70 2010 4453 4459
17. M. Götte, C. Kersting, I. Radke, L. Kiesel, and P. Wülfing An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ Breast Cancer Res 9 2007 R8
18. R.V. Iozzo, J.J. Zoeller, and A. Nyström Basement membrane proteoglycans: modulators par excellence of cancer growth and angiogenesis Mol Cells 27 2009 503 513
19. D. Aviezer, D. Hecht, M. Safran, M. Eisinger, G. David, and A. Yayon Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis Cell 79 1994 1005 1013
20. T. Nakamura, I. Ebihara, M. Fukui, S. Osada, I. Nagaoka, S. Horikoshi, Y. Tomino, and H. Koide Messenger RNA expression for growth factors in glomeruli from focal glomerular sclerosis Clin Immunol Immunopathol 66 1993 33 42
21. J. Floege, W. Kriz, M. Schulze, M. Susani, D. Kerjaschki, A. Mooney, W.G. Couser, and K.M. Koch Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy J Clin Invest 96 1995 2809 2819
22. W. Kriz, B. Hähnel, S. Rösener, and M. Elger Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis Kidney Int 48 1995 1435 1450
23. J. Chan, L. Prado-Lourenco, L.M. Khachigian, M.R. Bennett, B.A. Di Bartolo, and M.M. Kavurma TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner Circ Res 106 2010 1061 1071
24. M. Camozzi, S. Zacchigna, M. Rusnati, D. Coltrini, G. Ramirez-Correa, B. Bottazzi, A. Mantovani, M. Giacca, and M. Presta Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo Arterioscler Thromb Vasc Biol 25 2005 1837 1842
25. H. Rienstra, M. Boersema, G. Onuta, M.W. Boer, A. Zandvoort, M. van Riezen, J. Rozing, H. van Goor, G.J. Navis, E.R. Popa, and J.L. Hillebrands Donor and recipient origin of mesenchymal and endothelial cells in chronic renal allograft remodeling Am J Transplant 9 2009 463 472
26. M. Boersema, K. Katta, H. Rienstra, G. Molema, T.Q. Nguyen, R. Goldschmeding, G. Navis, J. van den Born, E.R. Popa, and J.L. Hillebrands Local medial microenvironment directs phenotypic modulation of smooth muscle cells after experimental renal transplantation Am J Transplant 12 2012 1429 1440
27. S.A. Asgeirsdottir, N. Werner, G. Harms, A. Van Den Berg, and G. Molema Analysis of in vivo endothelial cell activation applying RT-PCR following endothelial cell isolation by laser dissection microscopy Ann N Y Acad Sci 973 2002 586 589
28. J. van den Born, K. Gunnarsson, M.A. Bakker, L. Kjellén, M. Kusche-Gullberg, M. Maccarana, J.H. Berden, and U. Lindahl Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody J Biol Chem 270 1995 31303 31309
29. G. David, X.M. Bai, B. Van der Schueren, J.J. Cassiman, and H. Van den Berghe Developmental changes in heparan sulfate expression: in situ detection with mAbs J Cell Biol 119 1992 961 975
30. J.W. Celie, R.H. Beelen, and J. van den Born Effect of fixation protocols on in situ detection of L-selectin ligands J Immunol Methods 298 2005 155 159
31. P.H. Iverius Coupling of glycosaminoglycans to agarose beads (Sepharose 4B) Biochem J 124 1971 677 683
32. M. Maccarana, B. Casu, and U. Lindahl Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor [Erratum appeared in J Biol Chem 1994, 269:3903] J Biol Chem 268 1993 23898 23905
33. L. Wang, J.R. Brown, A. Varki, and J.D. Esko Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins J Clin Invest 110 2002 127 136
34. H. Morita, T. Shinzato, G. David, A. Mizutani, H. Habuchi, Y. Fujita, M. Ito, J. Asai, K. Maeda, and K. Kimata Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis Lab Invest 71 1994 528 535
35. S.M. Smith, L.A. West, P. Govindraj, X. Zhang, D.M. Ornitz, and J.R. Hassell Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors [Erratum appeared in Matrix Biol 2007, 26:583] Matrix Biol 26 2007 175 184
36. X. Guillonneau, J. Tassin, E. Berrou, M. Bryckaert, Y. Courtois, and F. Mascarelli In vitro changes in plasma membrane heparan sulfate proteoglycans and in perlecan expression participate in the regulation of fibroblast growth factor 2 mitogenic activity J Cell Physiol 166 1996 170 187
37. Y. Park, C. Rangel, M.M. Reynolds, M.C. Caldwell, M. Johns, M. Nayak, C.J. Welsh, S. McDermott, and S. Datta Drosophila perlecan modulates FGF and hedgehog signals to activate neural stem cell division Dev Biol 253 2003 247 257
38. A. Clayton, J. Thomas, G.J. Thomas, M. Davies, and R. Steadman Cell surface heparan sulfate proteoglycans control the response of renal interstitial fibroblasts to fibroblast growth factor-2 Kidney Int 59 2001 2084 2094
39. A. Francki, P. Uciechowski, J. Floege, J. von der Ohe, K. Resch, and H.H. Radeke Autocrine growth regulation of human glomerular mesangial cells is primarily mediated by basic fibroblast growth factor Am J Pathol 147 1995 1372 1382
40. F. Strutz The role of FGF-2 in renal fibrogenesis Front Biosci (Schol Ed) 1 2009 125 131
41. M.C. van Bruggen, B. Walgreen, T.P. Rijke, M.J. Corsius, K.J. Assmann, R.J. Smeenk, G.W. van Dedem, K. Kramers, and J.H. Berden Heparin and heparinoids prevent the binding of immune complexes containing nucleosomal antigens to the GBM and delay nephritis in MRL/lpr mice Kidney Int 50 1996 1555 1564
42. U. Gottmann, A. Mueller-Falcke, P. Schnuelle, R. Birck, V. Nickeleit, F.J. van der Woude, B.A. Yard, and C. Braun Influence of hypersulfated and low molecular weight heparins on ischemia/reperfusion: injury and allograft rejection in rat kidneys Transpl Int 20 2007 542 549
43. M. Ceol, G. Gambaro, U. Sauer, B. Baggio, F. Anglani, M. Forino, S. Facchin, L. Bordin, C. Weigert, A. Nerlich, and E.D. Schleicher Glycosaminoglycan therapy prevents TGF-beta1 overexpression and pathologic changes in renal tissue of long-term diabetic rats J Am Soc Nephrol 11 2000 2324 2336
44. S. Ashikari-Hada, H. Habuchi, N. Sugaya, T. Kobayashi, and K. Kimata Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate Glycobiology 19 2009 644 654
45. A.L. Rops, M.J. van den Hoven, M.M. Baselmans, J.F. Lensen, T.J. Wijnhoven, L.P. van den Heuvel, T.H. van Kuppevelt, J.H. Berden, and J. van der Vlag Heparan sulfate domains on cultured activated glomerular endothelial cells mediate leukocyte trafficking Kidney Int 73 2008 52 62